Faculty

Institution

Unit

Venue

Nazanin Majd

The University of Texas MD Anderson Cancer Center

Affiliations

Center Of Brain Tumour

The University of Texas MD Anderson Cancer Center

NoneNazanin Majd is currently serving as a Center Of Brain Tumour faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Nazanin Majd

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

neuro-oncology oncology brain tumor research gliomas cancer treatment neurology radiation oncology cancer research tumor biology medicine cancer care surgical oncology cancer immunotherapy oncogenes medicinal research neuroscience immunotherapy cancer biology cancer management clinical neurology molecular cancer pharmacotherapy malignant disease immune checkpoint inhibitors cancer cells cancer discovery vascular biology clinical radiation oncology anti-cancer agents tumor targeting cellular therapy tumor suppressors cancer genomics therapeutic efficacy radiation therapy neurosurgery cancer genetics tumoral pathology tumor innervation therapeutic targets cell death enzyme inhibition leukemia clinical immunology disease progression drug trials tumor heterogeneity cancer immunosurveillance pituitary carcinoma adult medulloblastoma recurrent glioblastoma gut microbes neuroinflammation novel therapies experimental biology pituitary gland pituitary disease gastrointestinal oncology viral oncology spinal tumors spinal oncology treatment resistance end results analysis tumor progression retrospective review phase ii study intrinsic interferon cancer prevention intraoperative consultation anti-tumor potential imp dehydrogenase inhibitors century-long story glioma progression myeloid-derived suppressor cells recurrent malignant glioma mesenchymal phenotype

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 5093: Assessing the Value of Cbv in Identifying Early Recurrence Risk in Glioblastoma. Cancer Research (2026)

molecular diagnosticsearly recurrence riskoncologyprognosisprognostic evaluationneuro-oncologyoncogenescancer treatmentbrain tumor researchgliomassurvival analysisneurologypathologyabstract 5093

672P Cystic Glioblastoma is Associated With Alterations of the Rb1 Pathway. Annals of Oncology (2025)

tumor biologycell regulationmolecular cancertumor suppressorscancer biologycell biologycell signalingneuro-oncologycancer cellsoncogenesbrain tumor researchgliomasrb1 pathwaymolecular biologycancer geneticspathologycystic glioblastoma

Abstract 1121: Pan-Cancer Prevalence of Unusual Mtap Alterations: Data From the Aacr Genie Database. Cancer Research (2025)

abstract 1121tumor biologymolecular diagnosticscancer researchradiation oncologyoncologymolecular cancerpancoast syndromeaacr genie databaseunusual mtap alterationscancer riskclinical researchpathology

Biom-21. Molecular and Clinical Determinants of Response to Immunotherapy in High-Grade Glioma. Neuro-Oncology (2025)

cancer immunotherapycellular therapyradiation oncologymolecular cancerneuro-oncologyimmunotherapyimmune checkpoint inhibitorsimmunologybrain tumor researchtumor innervationgliomas

Delayed Diagnosis of Amphetamine-Associated Cns Vasculitis Presenting as a Mass Lesion: Case Report and Literature Review. Annals of Internal Medicine Clinical Cases (2025)

Heitor Cabral FradeMuhammad QasimAkhil ShivaprasadGregory N. FullerAdel K. El-NaggarAshwin ViswanathanIvo W. Tremont-LukatsNazanin K. Majd

medicineclinical case reportcase studiesinternal medicinemass lesionliterature reviewclinical research

Dnar-08. Phase I Trial of Peposertib (Dna-Pk Inhibitor) Plus Radiation in Newly Diagnosed Mgmt-Unmethylated Glioblastoma, Updated Clinical, Radiographic, and Biomarker Outcomes. Neuro-Oncology (2025)

radiation therapyradiation oncologyneuro-oncologyclinical radiation oncologycancer treatmentbrain tumor researchgliomasneurology

Dual Targeting of Vegf and Pd-1: A Phase I/II Trial of Ivonescimab, a Novel Bispecific Antibody, in Recurrent Glioblastoma.. Journal of Clinical Oncology (2025)

cancer immunotherapyradiation oncologyneuro-oncologyimmune checkpoint inhibitorscancer treatmentbrain tumor researchgliomas

Efficacy and Safety of Dordaviprone (Onc201) in Prospective Clinical Trials of Adult and Pediatric Recurrent H3 K27M-Mutant Diffuse Glioma Patients.. Journal of Clinical Oncology (2025)

Ashley Love SumrallJoshua E. AllenStephen Joseph BagleyThomas BrundageNicholas A. ButowskiJessica ClymerAya HaggiagiCarl Johannes KoschmannSylvia Christine KurzTobey J. MacDonaldNazanin MajdSabine MuellerSam RamageRohinton TaraporeReena Parada ThomasYoshie UmemuraWafik Tharwat ZakyYazmin Odia

pediatricspharmacologygliomasneuroradiologyoncologycancer researchcancer treatmentbrain tumor researchneurologytherapeutic efficacyprospective cohort studiesneuro-oncologytumor targetingmedicinal researchsurgical oncologyprospective clinical trialsoncogenesclinical researchcancer genetics

Genomic Determinants of the Diffusely Infiltrative Gliomatosis Cerebri Phenotype. Journal of Neuro-Oncology (2025)

tumor heterogeneitymolecular diagnosticsneuropathologyneuro-oncologyoncogenesbrain tumor researchgenomic determinantsgliomasneurologypathology

Img-49. AI-Powered Mri Radiomics for Noninvasive Prediction of Cic Mutation, and Histologic Grade in Oligodendroglioma. Neuro-Oncology (2025)

neuroradiologymagnetic resonance imagingcic mutationcancer imagingradiomicsai-powered mri radiomicsradiation oncologyhistologic gradeneuro-oncologymedical imagingbrain tumor researchradiologygliomasneurologydiagnostic neuroradiologyneuroimaging

1
2
3
4
5
10
10 / page

Nazanin Majd

The University of Texas MD Anderson Cancer Center

Affiliations

Center Of Brain Tumour

The University of Texas MD Anderson Cancer Center

NoneNazanin Majd is currently serving as a Center Of Brain Tumour faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Nazanin Majd

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 5093: Assessing the Value of Cbv in Identifying Early Recurrence Risk in Glioblastoma. Cancer Research (2026)

molecular diagnosticsearly recurrence riskoncologyprognosisprognostic evaluationneuro-oncologyoncogenescancer treatmentbrain tumor researchgliomassurvival analysisneurologypathologyabstract 5093

672P Cystic Glioblastoma is Associated With Alterations of the Rb1 Pathway. Annals of Oncology (2025)

Abstract 1121: Pan-Cancer Prevalence of Unusual Mtap Alterations: Data From the Aacr Genie Database. Cancer Research (2025)

Biom-21. Molecular and Clinical Determinants of Response to Immunotherapy in High-Grade Glioma. Neuro-Oncology (2025)

cancer immunotherapycellular therapyradiation oncologymolecular cancerneuro-oncologyimmunotherapyimmune checkpoint inhibitorsimmunologybrain tumor researchtumor innervationgliomas

Delayed Diagnosis of Amphetamine-Associated Cns Vasculitis Presenting as a Mass Lesion: Case Report and Literature Review. Annals of Internal Medicine Clinical Cases (2025)

Heitor Cabral FradeMuhammad QasimAkhil ShivaprasadGregory N. FullerAdel K. El-NaggarAshwin ViswanathanIvo W. Tremont-LukatsNazanin K. Majd

medicineclinical case reportcase studiesinternal medicinemass lesionliterature reviewclinical research

radiation therapyradiation oncologyneuro-oncologyclinical radiation oncologycancer treatmentbrain tumor researchgliomasneurology

Dual Targeting of Vegf and Pd-1: A Phase I/II Trial of Ivonescimab, a Novel Bispecific Antibody, in Recurrent Glioblastoma.. Journal of Clinical Oncology (2025)

cancer immunotherapyradiation oncologyneuro-oncologyimmune checkpoint inhibitorscancer treatmentbrain tumor researchgliomas

Efficacy and Safety of Dordaviprone (Onc201) in Prospective Clinical Trials of Adult and Pediatric Recurrent H3 K27M-Mutant Diffuse Glioma Patients.. Journal of Clinical Oncology (2025)

Genomic Determinants of the Diffusely Infiltrative Gliomatosis Cerebri Phenotype. Journal of Neuro-Oncology (2025)

tumor heterogeneitymolecular diagnosticsneuropathologyneuro-oncologyoncogenesbrain tumor researchgenomic determinantsgliomasneurologypathology

Img-49. AI-Powered Mri Radiomics for Noninvasive Prediction of Cic Mutation, and Histologic Grade in Oligodendroglioma. Neuro-Oncology (2025)

1
2
3
4
5
10
10 / page